Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Old Pick#4 Cardiff Oncology; Positive Onvansertib Data RAS Mutant mCRC, Additional Data From Same Study 1st Half 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
GEN

Open-Source Model for Biotech

The hallmark of the new economy is innovation. Pressure to incentivize the economy to facilitate innovation has been a key driver of intellectual property (IP) law for generations. For years, there ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Wall Street Journal

Biotech Startups Use Models of Human Organs for Drug Discovery

Biotechnology startups are creating tiny models of human organs in an effort to speed the search for novel drugs. By devising more realistic models of human and disease biology, these startups aim to ...
Business Wire

Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models

NEWCASTLE, England--(BUSINESS WIRE)--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it ...